QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: mol.107.043208v1 73/3/758    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by De La Fuente, R. Articles by Verkman, A. S. Search for Related Content PubMed PubMed Citation Articles by De La Fuente, R. Articles by Verkman, A. S.

Small-Molecule Screen Identifies Inhibitors of a Human Intestinal Calcium-Activated Chloride Channel

Departments of Medicine and Physiology, Cardiovascular Research Institute, University of California, San Francisco, California

Calcium-activated chloride channels (CaCCs) are widely expressed in mammalian tissues, including intestinal epithelia, where they facilitate fluid secretion. Potent, selective CaCC inhibitors have not been available. We established a high-throughput screen for identification of inhibitors of a human intestinal CaCC based on inhibition of ATP/carbachol-stimulated iodide influx in HT-29 cells after lentiviral infection with the yellow fluorescent halide-sensing protein YFP-H148Q/I152L. Screening of 50,000 diverse, drug-like compounds yielded six classes of putative CaCC inhibitors, two of which, 3-acyl-2-aminothiophenes and 5-aryl-2-aminothiazoles, inhibited by >95% iodide influx in HT-29 cells in response to multiple calcium-elevating agonists, including thapsigargin, without inhibition of calcium elevation, calcium-calmodulin kinase II activation, or cystic fibrosis transmembrane conductance regulator chloride channels. These compounds also inhibited calcium-dependent chloride secretion in T84 human intestinal epithelial cells. Patch-clamp analysis indicated inhibition of CaCC gating, which, together with the calcium-calmodulin data, suggests that the inhibitors target the CaCC directly. Structure-activity relationships were established from analysis of more than 1800 analogs, with IC₅₀ values of the best analogs down to 1 µM. Small-molecule CaCC inhibitors may be useful in pharmacological dissection of CaCC functions and in reducing intestinal fluid losses in CaCC-mediated secretory diarrheas.

This article has been cited by other articles:

				W. Namkung, Y. Song, A. D. Mills, P. Padmawar, W. E. Finkbeiner, and A. S. Verkman In Situ Measurement of Airway Surface Liquid [K+] Using a Ratioable K+-sensitive Fluorescent Dye J. Biol. Chem., June 5, 2009; 284(23): 15916 - 15926. [Abstract] [Full Text] [PDF]

				H. C. Hartzell, K. Yu, Q. Xiao, L.-T. Chien, and Z. Qu Anoctamin/TMEM16 family members are Ca2+-activated Cl\#8722; channels J. Physiol., May 1, 2009; 587(10): 2127 - 2139. [Abstract] [Full Text] [PDF]

				E. Delpire, E. Days, L. M. Lewis, D. Mi, K. Kim, C. W. Lindsley, and C. D. Weaver Small-molecule screen identifies inhibitors of the neuronal K-Cl cotransporter KCC2 PNAS, March 31, 2009; 106(13): 5383 - 5388. [Abstract] [Full Text] [PDF]